Paediatric Inflammatory Multisystem Syndrome (PIMS) and COVID-19:  What Canadian healthcare providers need to know now

Last modified by Paula Robeson on 2020/06/18 21:40

What is “Paediatric Inflammatory Multisystem Syndrome”? What is the relationship between PIMS and the COVID-19 pandemic? Who is at risk? How can we effectively diagnose and treat this novel condition? What can we learn from other jurisdictions? What will the future hold? As SARS-Co-V2 continues to upend every facet of daily life in Canada, and around the world, news of a novel, rare, and potentially deadly hyperinflammatory syndrome affecting children has worried parents, and has activated the global paediatric clinical community. 

This webinar will provide an overview of the current epidemiology of COVID-19 in Canada, with a focus on the newly defined Paediatric Hyperinflammatory Multisystem Syndrome (PIMS).  The clinical presentation for PIMS will be reviewed, and a practical diagnostic approach will be outlined.  Evidence-based therapies will be described and lessons from other nations will be shared. Public health reporting of this condition, via the Canadian Paediatric Surveillance Program, will also be explained.

The content of this webinar will be based on a (soon to be released) Canadian Paediatric Society Practice Point on the Diagnosis and Management of Paediatric Inflammatory Multisystem Syndrome in Canadian Children. 

Primary audience:

  • Front-line service providers (MDs, NPs, RNs) in community practice, EDs, acute care 
  • Public health officials

Following this session, participants will be able to:

  • Recognize and diagnose Paediatric Inflammatory Multisystem Syndrome (PIMS) temporally associated with COVID-19 
  • Understand evidence-based therapies for PIMS 
  • Appreciate the importance of public health surveillance reporting during the COVID-19 pandemic 

Chair

Dr. Rae Yeung, Rheumatology, The Hospital for Sick Children

Presenters

Dr. Rosie Scuccimarri, Rheumatology, Montreal Children's Hospital

Dr. Elie Haddad, Immunology and Rheumatology, Ste-Justine Hospital 

Dr. Marie-Paule Morin, Immunology and Rheumatology, Ste. Justine Hospital 

Dr. Roberta Berard, Rheumatology, University of Western Ontario

Tags:
Created by Paula Robeson on 2020/05/21 20:01